Breast Screening Clinical Trial
Official title:
International Randomized Study Comparing Personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70
MyPeBS is an international randomized, open-label, multicentric, study assessing the effectiveness of a risk-based breast cancer screening strategy (using clinical risk scores and polymorphisms) compared to standard screening (according to the current national guidelines in each participating country) in detecting stage 2 or higher breast cancers. Women will be differentially screened for 4 years and then, after an end-of-study mammogram, they will return to the routine screening practice. The main study endpoint will be measured at the end of the four years of intervention. Furthermore, follow up data will be collected for 15 years from study entry for evaluation of long-term cumulative breast cancer incidence and breast cancer-specific survival
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03233191 -
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
|
Phase 3 | |
| Completed |
NCT01977599 -
Are Text Message Reminders an Effective Intervention for Improving the Uptake of Breast Screening?
|
N/A | |
| Completed |
NCT02174406 -
Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
|
||
| Active, not recruiting |
NCT04761055 -
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
|
N/A | |
| Completed |
NCT03846947 -
Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study
|
N/A | |
| Terminated |
NCT03929822 -
Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis
|